Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

The study presents positive preclinical data for the treatment of KRASG12C mutant non-small cell lung cancer (NSCLC ... in non-viral lipid nanoparticles, targets cancer cells specifically ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...

Folic acid plays a dual role in breast cancer depending on dose and context. While moderate intake may reduce risk, high ...

Cancer Gene Therapy Market Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED ST ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it has signed an ...

The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This report aims to provide a ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The world of oncology is evolving rapidly, with breakthrough technologies transforming the way cancer is treated and managed.